Eagle Pharmaceuticals Inc
NASDAQ:EGRX 3:59:58 PM EDT
| Market Cap (Intraday) | 616.87M |
| Current PE | 109.65 |
| Forward PE | 17.5 |
| 2yr Forward PE | 7.41 |
| 10-Day MA | $49.81 |
| 50-Day MA | $52.76 |
| 200-Day MA | $46.60 |
Eagle Pharmaceuticals Inc Stock, NASDAQ:EGRX
50 Tice Boulevard, Suite 315, Woodcliff Lake, New Jersey 07677-9991
United States of America
Phone: +1.201.326.5300
Number of Employees: 106
Description
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.